This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Laragh, J. H. Search for Related Content PubMed PubMed Citation Articles by Laragh, J. H.

Hypertension, Vol 20, 267-279, Copyright © 1992 by American Heart Association

ARTICLES

Lewis K. Dahl Memorial Lecture. The renin system and four lines fo hypertension research. Nephron heterogeneity, the calcium connection, the prorenin vasodilator limb, and plasma renin and heart attack

JH Laragh
Cardiovascular Center, New York Hospital-Cornell Medical Center, N.Y. 10021.

As the major regulator of arterial blood pressure and sodium balance, the renin axis supports normotension or hypertension via angiotensin- mediated vasoconstriction and angiotensin plus aldosterone-induced renal sodium retention. In this endocrine servo control, renal renin is released by hypotension or salt depletion; conversely, with hypertension or volume excess, plasma renin activity falls to zero. Accordingly, any renal renin secretion is abnormal in the face of arterial hypertension. Human hypertensive disorders comprise a spectrum of abnormal vasoconstriction-volume products (renin-sodium profiles). Excess plasma renin activity for the sodium balance is created by nephron heterogeneity in which a subpopulation of ischemic nephrons hypersecretes renin and retains sodium. This excess renin impairs adaptive natriuresis of neighboring normal nephrons. Research defining the pivotal role of vascular cytosolic calcium for transducing sodium or renin-mediated vasoconstriction explains the selective value of calcium antagonists for correcting the sodium-volume-mediated, and beta- blockers or angiotensin converting enzyme inhibitors for correcting renin-mediated, arteriolar vasoconstriction. The renin precursor prorenin appears to be physiologically active, causing selective vasodilation that offsets renin-mediated vasoconstriction. Overactivity of prorenin may be involved in the hyperperfusion vascular injuries of diabetes mellitus and toxemias. Prorenin underactivity may facilitate renin-mediated ischemic vascular injury. In essential hypertension, undue plasma renin activity is powerfully and independently associated with heart attack risk. Conversely, patients with low renin activity are protected from heart attack despite higher blood pressures and greater age. Also, renin or angiotensin administration consistently causes vascular injury in the heart, brain, and kidneys of animals. These data suggest new potentials for the prevention of cardiovascular sequelae (heart attack and stroke) by using explicit strategies to curtail plasma renin activity.

This article has been cited by other articles:

				L. Anton and K. B. Brosnihan Review: Systemic and uteroplacental renin--angiotensin system in normal and pre-eclamptic pregnancies Therapeutic Advances in Cardiovascular Disease, October 1, 2008; 2(5): 349 - 362. [Abstract] [PDF]

				N. I. Parikh, P. Gona, M. G. Larson, T. J. Wang, C. Newton-Cheh, D. Levy, E. J. Benjamin, W. B. Kannel, and R. S. Vasan Plasma renin and risk of cardiovascular disease and mortality: the Framingham Heart Study Eur. Heart J., November 1, 2007; 28(21): 2644 - 2652. [Abstract] [Full Text] [PDF]

				N. Schupp, U. Schmid, P. Rutkowski, U. Lakner, N. Kanase, A. Heidland, and H. Stopper Angiotensin II-induced genomic damage in renal cells can be prevented by angiotensin II type 1 receptor blockage or radical scavenging Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1427 - F1434. [Abstract] [Full Text] [PDF]

				M. Paul, A. Poyan Mehr, and R. Kreutz Physiology of local Renin-Angiotensin systems. Physiol Rev, July 1, 2006; 86(3): 747 - 803. [Abstract] [Full Text] [PDF]

				D. L. Lee, R. C. Webb, and M. W. Brands Sympathetic and angiotensin-dependent hypertension during cage-switch stress in mice Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1394 - R1398. [Abstract] [Full Text] [PDF]

				F. D. Grant, J. R. Romero, X. Jeunemaitre, S. C. Hunt, P. N. Hopkins, N. H. Hollenberg, and G. H. Williams Low-Renin Hypertension, Altered Sodium Homeostasis, and an {alpha}-Adducin Polymorphism Hypertension, February 1, 2002; 39(2): 191 - 196. [Abstract] [Full Text] [PDF]

				A. Chiolero, G. Wurzner, and M. Burnier Renal determinants of the salt sensitivity of blood pressure Nephrol. Dial. Transplant., March 1, 2001; 16(3): 452 - 458. [Full Text] [PDF]

				Y. Kusaka, R. A. Kelly, G. H. Williams, and I. Kifor Coronary microvascular endothelial cells cosecrete angiotensin II and endothelin-1 via a regulated pathway Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1087 - H1096. [Abstract] [Full Text] [PDF]

				S. Tomita, N. Tomita, T. Yamada, L. Zhang, Y. Kaneda, R. Morishita, T. Ogihara, V. J. Dzau, and M. Horiuchi Transcription Factor Decoy to Study the Molecular Mechanism of Negative Regulation of Renin Gene Expression in the Liver In Vivo Circ. Res., May 14, 1999; 84(9): 1059 - 1066. [Abstract] [Full Text] [PDF]

				R. A. Preston, B. J. Materson, D. J. Reda, D. W. Williams, R. J. Hamburger, W. C. Cushman, R. J. Anderson, and for the Department of Veterans Affairs Cooperative Age-Race Subgroup Compared With Renin Profile as Predictors of Blood Pressure Response to Antihypertensive Therapy JAMA, October 7, 1998; 280(13): 1168 - 1172. [Abstract] [Full Text] [PDF]

				M. Maguchi, K. Kohara, T. Okura, Shimin Li, M. Takezaki, W. Nishida, and K. Hiwada Angiotensin-Converting Enzyme Gene Polymorphism in Essential Hypertensive Patients in Japanese Population Angiology, July 1, 1996; 47(7): 643 - 648. [Abstract] [PDF]